Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

RAD18 transmits DNA damage signalling to elicit homologous recombination repair.

Nature cell biology | 2009

To maintain genome stability, cells respond to DNA damage by activating signalling pathways that govern cell-cycle checkpoints and initiate DNA repair. Cell-cycle checkpoint controls should connect with DNA repair processes, however, exactly how such coordination occurs in vivo is largely unknown. Here we describe a new role for the E3 ligase RAD18 as the integral component in translating the damage response signal to orchestrate homologous recombination repair (HRR). We show that RAD18 promotes homologous recombination in a manner strictly dependent on its ability to be recruited to sites of DNA breaks and that this recruitment relies on a well-defined DNA damage signalling pathway mediated by another E3 ligase, RNF8. We further demonstrate that RAD18 functions as an adaptor to facilitate homologous recombination through direct interaction with the recombinase RAD51C. Together, our data uncovers RAD18 as a key factor that orchestrates HRR through surveillance of the DNA damage signal.

Pubmed ID: 19396164 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA089239-08
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092312-06
  • Agency: NCI NIH HHS, United States
    Id: R01 CA130899
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089239-07
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092312-09
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092312-08
  • Agency: NCI NIH HHS, United States
    Id: R01 CA132755-03
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089239-09
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092312
  • Agency: NCI NIH HHS, United States
    Id: R01 CA130899-02
  • Agency: NCI NIH HHS, United States
    Id: R01 CA132755
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089239-06
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089239
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092312-07

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Bethyl (tool)

RRID:SCR_013554

An Antibody supplier

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

HCC1937 (tool)

RRID:CVCL_0290

Cell line HCC1937 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U2OS (tool)

RRID:CVCL_0042

Cell line U2OS is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HCT 116 (tool)

RRID:CVCL_0291

Cell line HCT 116 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions